ResMed Inc.RMDNYSE
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank79
3Y CAGR+27.7%
5Y CAGR+74.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+27.7%/yr
vs -53.4%/yr prior
5Y CAGR
+74.2%/yr
Recent deceleration
Acceleration
+81.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
16x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 13.03% |
| Q3 2025 | -8.11% |
| Q2 2025 | 4.02% |
| Q1 2025 | 5.96% |
| Q4 2024 | 10.85% |
| Q3 2024 | 6.53% |
| Q2 2024 | -2.45% |
| Q1 2024 | 43.66% |
| Q4 2023 | -4.70% |
| Q3 2023 | -4.49% |
| Q2 2023 | -1.27% |
| Q1 2023 | 3.27% |
| Q4 2022 | 6.25% |
| Q3 2022 | 8.27% |
| Q2 2022 | 9.02% |
| Q1 2022 | -11.59% |
| Q4 2021 | -1.43% |
| Q3 2021 | 4.48% |
| Q2 2021 | 348.15% |
| Q1 2021 | -143.55% |
| Q4 2020 | 0.81% |
| Q3 2020 | 0.00% |
| Q2 2020 | 8.85% |
| Q1 2020 | 1.80% |
| Q4 2019 | 32.14% |
| Q3 2019 | 75.00% |
| Q2 2019 | -35.14% |
| Q1 2019 | -14.94% |
| Q4 2018 | 17.57% |
| Q3 2018 | -3.90% |
| Q2 2018 | 0.00% |
| Q1 2018 | 1052.69% |
| Q4 2017 | -89.05% |
| Q3 2017 | -15.28% |
| Q2 2017 | 16.13% |
| Q1 2017 | 14.81% |
| Q4 2016 | 0.00% |
| Q3 2016 | -8.47% |
| Q2 2016 | -6.35% |
| Q1 2016 | -7.35% |